Thanks to better cancer treatment, many cancer survivors are able to live long after their cancer diagnosis. Some cancer treatments increase the risk of long-term unwanted effects. These “late effects,” such as heart disease or second primary cancers, can drastically reduce survivors’ quality of life. Our group is focused on identifying who exactly has the greatest risk of late effects and finding the best ways to detect these effects earlier. We use imaging, genetics, and epidemiology to advance the science of late effects and improve the outcomes for cancer survivors.
